Effect of growth hormone on in vitro osteogenesis and gene expression of human osteoblastic cells is donor-age-dependent

Journal of Cellular Biochemistry

Volumn 104, Issue 2, 2008, Pages 369-376

  Crippa, Grasiele E ^a   Beloti, Marcio M ^a   Cardoso, Cristina R ^a   Silva, João S ^a   Rosa, Adalberto L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aging; Gene expression; Growth hormone; in vitro osteogenesis; Osteoblastic cells

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; GROWTH HORMONE; MESSENGER RNA; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2;

ADOLESCENT; ADULT; ALVEOLAR BONE; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; OSSIFICATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGE FACTORS; BIOLOGICAL MARKERS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMAN GROWTH HORMONE; HUMANS; MIDDLE AGED; OSTEOBLASTS; OSTEOGENESIS; RNA, MESSENGER; UP-REGULATION;

EID: 43449100935     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21628     Document Type: Article

References (36)

1. Arvat E, Ceda GP, Di Vito L, Ramunni J, Gianotti L, Broglio F, Deghenghi R, Ghigo E. 1998. Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging. Pituitary 1:51-58.
2. Beck GR, Jr., Moran E, Knecht N. 2003. Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. Exp Cell Res 288:288-300.
3. Bellows CG, Heersche JN, Aubin JE. 1992. Inorganic phosphate added exogenously or released from beta-glycerophosphate initiates mineralization of osteoid nodulos in vitro. Bone Min 17:15-19.
4. Bonkowski MS, Pamenter RW, Rocha JS, Masternak MM, Panici JA, Bartke A. 2006. Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics. J Gerontol A Biol Sci Med Sci 61:562-567.
5. Coelho MJ, Fernandes MH. 2000. Human bone cell cultures in biocompatibility testing. Part II: Effect of ascorbic acid, beta- glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 21:1095-1102.
6. Cooper LF, Masuda T, Yliheikkila PK, Felton DA. 1998. Generalizations regarding the process and phenomenon of osseointegration. Part II. In vitro studies. Int J Oral Maxillofac Implants 13:163-174.
7. Corpas E, Harman MS, Blackman MR. 1993. Human growth hormone and human aging. Endocr Rev 14: 20-39.
8. Davidson P, Milne R, Chase D, Cooper C. 2004. Growth hormone replacement in adults and bone mineral density: A systematic review and meta-analysis. Clin Endocrinol (Oxf) 60:92-98.
9. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
10. Gerland K, Bataille-Simoneau N, Basle M, Fourcin M, Gascan H, Mercier L. 2000. Activation of the Jak/Stat signal transduction pathway in GH-treated rat osteoblast-like cells in culture. Mol Cell Endocrinol 168:1-9.
11. Gregory CA, Gunn WG, Peister A, Prockop DJ. 2004. An Alizarin red-based assay of mineralization by adherent cells in culture: Comparison with cetylpyridinium chloride extraction. Anal Biochem 329:77-84.
12. Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, Komori T, Nakatsuka M. 1999. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 274:6972-6978.
13. Hoang QQ, Sicheri F, Howard A, Yang DS. 2003. Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 425:977-980.
14. Hubina E, Kovacs L, Szabolcs I, Szücs N, Tóth M, Rácz K, Czirják S, Görömbey Z, Góth MI. 2004. The effect of gender and age on growth hormone replacement in growth hormone-deficient patients. Horm Metab Res 36:247-253.
15. Johannsson G, Svensson J, Bengtsson BA. 2000. Growth hormone and ageing. Growth Horm IGF Res 10 (Suppl B):S25-S30.
16. Kassem M, Blum W, Ristelli J, Mosekilde L, Eriksen EF. 1993. Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 52:222-226.
17. Kassem M, Brixen K, Mosekilde L, Eriksen EF. 1994a. Human marrow stromal osteoblast-like cells do not show reduced responsiveness to in vitro stimulation with growth hormone in patients with postmenopausal osteoporosis. Calcif Tissue Int 54:1-6.
18. Kassem M, Mosekilde L, Eriksen EF. 1994b. Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro. Growth Regul 4:131-135.
19. Laursen T. 2004. Clinical pharmacological aspects of growth hormone administration. Growth Horm IGF Res 14: 16-44.
20. Lieberman SA, Mitchell AM, Marcus R, Hintz RL, Hoffman AR. 1994. The insulin-like growth factor I generation test: Resistance to growth hormone with aging and estrogen replacement therapy. Horm Metab Res 26: 229-233.
21. Livak K-L, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT method. Methods 25:402-408.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
23. Mailhot JM, Borke JL. 1998. An isolation and in vitro culturing method for human intraoral bone cells derived from dental implant preparation sites. Clin Oral Implants Res 9:43-50.
24. McKee MD, Nanci A. 1996. Osteopontin: An interfacial extracellular matrix protein in mineralised tissues. Connect Tissue Res 35:197-205.
25. Olsen BR. 1996. Morphogenesis: Collagen it takes an bone it makes. Curr Biol 6:645-647.
26. Owen T, Aronow M, Shalhoub V, Barone L, Wilming L, Tassinari M, Kennedy M, Pockwinse S, Lian J, Stein G. 1990. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:357-370.
27. Patterson M, Jr. 1979. Measurement of growth and viability of cells in culture. Methods Enzymol 58:141-152.
28. Pfeilschifter J, Diel I, Pilz U, Brunotte K, Naumann A, Ziegler R. 1993. Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age. J Bone Miner Res 8:707-717.
29. Reddy GK, Enwemeka CS. 1996. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29:225-229.
30. Rosa AL, Beloti MM. 2003. Effect of cpTi surface roughness on human bone marrow cell attachment, proliferation, and differentiation. Braz Dent J 14:16-21.
31. Slootweg MC, van Buul-Offers SC, Herrmann-Erlee MP, Duursma SA. 1988a. Direct stimulatory effect of growth hormone on DNA synthesis of fetal chicken osteoblasts in culture. Acta Endocrinol (Copenh) 118:294-300.
32. Slootweg MC, van Buul-Offers SC, Herrmann-Erlee MP, van der Meer JM, Duursma SA. 1988b. Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells. J Endocrinol 116:R11-R13.
33. Ueland T. 2004. Bone metabolism in relation to alterations in systemic growth hormone. Growth Horm IGF Res 14:404-417.
34. Välimäki MJ, Salmela PI, Salmi J, Vikari J, Kataja M, Turumen H, Soppi E. 1999. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults. Eur J Endocrinol 140:545-554. 140.
35. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G, Kopchick JJ. 1997. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:13215-13220.
36. Zur Nieden N, Kempka G, Ahr HJ. 2003. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 71:18-127.